morphiceptin has been researched along with 3-nitro-2-pyridinesulfenyl in 1 studies
| Studies (morphiceptin) | Trials (morphiceptin) | Recent Studies (post-2010) (morphiceptin) | Studies (3-nitro-2-pyridinesulfenyl) | Trials (3-nitro-2-pyridinesulfenyl) | Recent Studies (post-2010) (3-nitro-2-pyridinesulfenyl) |
|---|---|---|---|---|---|
| 139 | 0 | 12 | 11 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, M; Matsumoto, H; Ohno, M; Sakamoto, H; Shimohigashi, Y; Takada, K; Yasunaga, T | 1 |
1 other study(ies) available for morphiceptin and 3-nitro-2-pyridinesulfenyl
| Article | Year |
|---|---|
Discriminative affinity labelling of opioid receptors by enkephalin and morphiceptin analogues containing 3-nitro-2-pyridinesulphenyl-activated thiol residues.
Topics: Affinity Labels; Amino Acid Sequence; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; Indicators and Reagents; Molecular Sequence Data; Peptides; Pyridines; Radioligand Assay; Receptors, Opioid | 1992 |